載入...
Clinical Outlook for Type-1 and FOXP3(+) T Regulatory Cell-Based Therapy
T regulatory cells (Tregs) are subsets of T lymphocytes specialized in modulating antigen-specific immune responses in vivo. Hence, Tregs represent an ideal therapeutic tool to control detrimental immune reactions. Based on solid pre-clinical results, investigators started testing the safety and eff...
Na minha lista:
| 發表在: | Front Immunol |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4658444/ https://ncbi.nlm.nih.gov/pubmed/26635807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2015.00593 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|